Contrast-Associated Acute Kidney Injury (CA-AKI) in Children: Special Considerations
10.3339/jkspn.2019.23.2.77
- Author:
Martin WINDPESSL
1
;
Andreas KRONBICHLER
Author Information
1. Department of Internal Medicine IV (Nephrology Section), Klinikum Wels-Grieskirchen, Grieskirchner Straße 42, 4600 Wels, Austria. martin.windpessl@klinikum-wegr.at
- Publication Type:Review
- Keywords:
Contrast Media;
Acute Kidney Injury;
Renal Insufficiency
- MeSH:
Acute Kidney Injury;
Biomarkers;
Child;
Contrast Media;
Diuretics;
Humans;
Incidence;
Renal Insufficiency
- From:Childhood Kidney Diseases
2019;23(2):77-85
- CountryRepublic of Korea
- Language:English
-
Abstract:
Contrast-associated acute kidney injury (CA-AKI) is a major concern when iodinated contrast material is administered, especially in patients at risk. Efforts have been undertaken to understand the detrimental effects of contrast media (CM). With the use of low-osmolar or iso-osmolar CM the incidence of CA-AKI has steadily decreased within the past decade; however, especially in the pediatric population information is scarce. Incidence rates have been reported to range between 0% to 18.75%, particularly depending on indication, selection of population (i.e. preexisting co-morbidities), and definition of AKI. Different biomarkers have been proposed, but confirmatory studies are either lacking or have contributed to their lack of diagnostic power. Proteomic approaches have been employed and may pave the way to such discovery. Prevention strategies have been tested and proposed, but the recently published AMACING and PRESERVE trials have shown that commonly used strategies (such as systematic hydration or administration of N-acetylcysteine) have no role in the prevention of CA-AKI. We propose that thoughtful assessment of one's fluid state is the most appropriate approach and depending on the hydration status diuretics or fluid administration should be provided to achieve an euvolemic state ahead of contrast exposure.
